A Study of MK-6552 in Sleep Deprived Healthy Participants (MK-6552-003)

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy, Narcolepsy

In brief

This study examined the safety of the drug MK-6552 and if people tolerated it. It also studied whether MK-6552 works better than placebo for staying awake in sleep deprived healthy participants.

Key facts

Study ID

NCT06619665

Run by

Merck Sharp & Dohme LLC

People needed

18

Starts

2024-03-19

Expected to finish

2024-07-16

Last updated by the study team

2024-10-01

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Criteria include but are not limited to the following:
• Is in good health
• Body Mass Index (BMI) between 18 and 32 kg/m\^2, inclusive.

You may not qualify if…

• Criteria include but are not limited to the following:
• History of or current hypertension,
• Has a history of sleep disorders:

Where it is running

• NeuroTrials Research Inc (Site 0001) — Atlanta, Georgia, United States
• Clinilabs (Site 0003) — Eatontown, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.